GL1X · GenesisL1 explorer

UniProt Q5HK89

CRISPR system single-strand-specific deoxyribonuclease Cas10/Csm1 (subtype III-A) (Q5HK89)

CRISPR system single-strand-specific deoxyribonuclease Cas10/Csm1 (subtype III-A) (UniProt Q5HK89): 11 experimental structures on GenesisL1, 1 ligand bound, 28 pockets. Binding sites, pockets, druggability and 3D structures in…

UniProt
Q5HK89
Protein
CRISPR system single-strand-specific deoxyribonuclease Cas10/Csm1 (subtype…
Experimental structures
11
Predicted models
0
Ligands
1
Pockets
28 · 4 records with a druggable one

Structures

11 records of Q5HK89 in the MolNFT archive: 11 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
7UZWStaphylococcus epidermidis RP62a CRISPR effector subcomplexelectron microscopyF—6 (best 0.81)
7UZWStaphylococcus epidermidis RP62A CRISPR effector subcomplexelectron microscopyF——
7UZXStaphylococcus epidermidis RP62a CRISPR effector subcomplex with non-self target RNA boundelectron microscopyF—7 (best 0.81)
7UZXStaphylococcus epidermidis RP62A CRISPR effector subcomplex with non- self target RNA boundelectron microscopyF——
7UZYStaphylococcus epidermidis RP62A CRISPR effector complex with non-self target RNA 2electron microscopyF——
7UZZStaphylococcus epidermidis RP62a CRISPR tall effector complexelectron microscopyF—7 (best 0.82)
7UZZStaphylococcus epidermidis RP62A CRISPR tall effector complexelectron microscopyF——
7V00Staphylococcus epidermidis RP62A CRISPR tall effector complex with bound ATPelectron microscopyFATP—
7V01Staphylococcus epidermidis RP62a CRISPR short effector complex with self RNA target and ATPelectron microscopyFATP8 (best 0.82)
7V01Staphylococcus epidermidis RP62A CRISPR short effector complex with self RNA target and ATPelectron microscopyFATP—
7V02Staphylococcus epidermidis RP62A CRISPR short effector complexelectron microscopyF——

Ligands

  • ATP · Adenosine-5'-triphosphate · in 3 records

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.